Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies

High risk Neuroblastoma (NB) includes aggressive, metastatic solid tumors of childhood. The survival rate improved only modestly, despite the use of combination therapies including novel immunotherapies based on the antibody-mediated targeting of tumor-associated surface ligands. Treatment failures...

Full description

Bibliographic Details
Main Authors: Alessandra Marrella, Alessandra Dondero, Maurizio Aiello, Beatrice Casu, Daniel Olive, Stefano Regis, Cristina Bottino, Daniela Pende, Raffaella Meazza, Guido Caluori, Roberta Castriconi, Silvia Scaglione
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01876/full
_version_ 1811324391942782976
author Alessandra Marrella
Alessandra Dondero
Maurizio Aiello
Beatrice Casu
Daniel Olive
Stefano Regis
Cristina Bottino
Cristina Bottino
Daniela Pende
Raffaella Meazza
Guido Caluori
Guido Caluori
Roberta Castriconi
Roberta Castriconi
Silvia Scaglione
Silvia Scaglione
author_facet Alessandra Marrella
Alessandra Dondero
Maurizio Aiello
Beatrice Casu
Daniel Olive
Stefano Regis
Cristina Bottino
Cristina Bottino
Daniela Pende
Raffaella Meazza
Guido Caluori
Guido Caluori
Roberta Castriconi
Roberta Castriconi
Silvia Scaglione
Silvia Scaglione
author_sort Alessandra Marrella
collection DOAJ
description High risk Neuroblastoma (NB) includes aggressive, metastatic solid tumors of childhood. The survival rate improved only modestly, despite the use of combination therapies including novel immunotherapies based on the antibody-mediated targeting of tumor-associated surface ligands. Treatment failures may be due to the lack of adequate in vitro models for studying, in a given patient, the efficacy of potential therapeutics, including those aimed to enhance anti-tumor immune responses. We here propose a 3D alginate-based hydrogel as extracellular microenvironment to evaluate the effects of the three-dimensionality on biological and immunological properties of NB cells. NB cell lines grown within the 3D alginate spheres presented spheroid morphology, optimal survival, and proliferation capabilities, and a reduced sensitivity to the cytotoxic effect of imatinib mesylate. 3D cultured NB cells were also evaluated for the constitutive and IFN-γ-induced expression of surface molecules capable of tuning the anti-tumor activity of NK cells including immune checkpoint ligands. In particular, IFN-γ induced de novo expression of high amounts of HLA-I molecules, which protected NB cells from the attack mediated by KIR/KIR-L matched NK cells. Moreover, in the 3D alginate spheres, the cytokine increased the expression of the immune checkpoint ligands PD-Ls and B7-H3 while virtually abrogating that of PVR, a ligand of DNAM-1 activating receptor, whose expression correlates with high susceptibility to NK-mediated killing. Our 3D model highlighted molecular features that more closely resemble the immunophenotypic variants occurring in vivo and not fully appreciated in classical 2D culture conditions. Thus, based on our results, 3D alginate-based hydrogels might represent a clinical-relevant cell culture platform where to test the efficacy of personalized therapeutic approaches aimed to optimize the current and innovative immune based therapies in a very systematic and reliable way.
first_indexed 2024-04-13T14:13:26Z
format Article
id doaj.art-a38c4171e38547d9b6023846f4c5d30a
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T14:13:26Z
publishDate 2019-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-a38c4171e38547d9b6023846f4c5d30a2022-12-22T02:43:43ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-08-011010.3389/fimmu.2019.01876457284Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to TherapiesAlessandra Marrella0Alessandra Dondero1Maurizio Aiello2Beatrice Casu3Daniel Olive4Stefano Regis5Cristina Bottino6Cristina Bottino7Daniela Pende8Raffaella Meazza9Guido Caluori10Guido Caluori11Roberta Castriconi12Roberta Castriconi13Silvia Scaglione14Silvia Scaglione15CNR—IEIIT Institute, National Research Council of Italy, Genoa, ItalyDepartment of Experimental Medicine, University of Genoa, Genoa, ItalyReact4life S.r.l., Genoa, ItalyDepartment of Experimental Medicine, University of Genoa, Genoa, ItalyTumor Immunology Team, IBISA Immunomonitoring Platform, Cancer Research Center of Marseille, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, FranceLaboratory of Clinical and Experimental Immunology, IRCCS Giannina Gaslini, Genoa, ItalyDepartment of Experimental Medicine, University of Genoa, Genoa, ItalyLaboratory of Clinical and Experimental Immunology, IRCCS Giannina Gaslini, Genoa, ItalyLaboratorio di Immunologia, IRCCS Ospedale Policlinico San Martino, Genoa, ItalyLaboratorio di Immunologia, IRCCS Ospedale Policlinico San Martino, Genoa, ItalyFNUSA-ICRC, Interventional Cardiac Electrophysiology, Brno, CzechiaNanobiotechnology, CEITEC Masaryk University, Brno, CzechiaDepartment of Experimental Medicine, University of Genoa, Genoa, ItalyCentre of Excellence for Biomedical Research, CEBR, University of Genoa, Genoa, ItalyCNR—IEIIT Institute, National Research Council of Italy, Genoa, ItalyReact4life S.r.l., Genoa, ItalyHigh risk Neuroblastoma (NB) includes aggressive, metastatic solid tumors of childhood. The survival rate improved only modestly, despite the use of combination therapies including novel immunotherapies based on the antibody-mediated targeting of tumor-associated surface ligands. Treatment failures may be due to the lack of adequate in vitro models for studying, in a given patient, the efficacy of potential therapeutics, including those aimed to enhance anti-tumor immune responses. We here propose a 3D alginate-based hydrogel as extracellular microenvironment to evaluate the effects of the three-dimensionality on biological and immunological properties of NB cells. NB cell lines grown within the 3D alginate spheres presented spheroid morphology, optimal survival, and proliferation capabilities, and a reduced sensitivity to the cytotoxic effect of imatinib mesylate. 3D cultured NB cells were also evaluated for the constitutive and IFN-γ-induced expression of surface molecules capable of tuning the anti-tumor activity of NK cells including immune checkpoint ligands. In particular, IFN-γ induced de novo expression of high amounts of HLA-I molecules, which protected NB cells from the attack mediated by KIR/KIR-L matched NK cells. Moreover, in the 3D alginate spheres, the cytokine increased the expression of the immune checkpoint ligands PD-Ls and B7-H3 while virtually abrogating that of PVR, a ligand of DNAM-1 activating receptor, whose expression correlates with high susceptibility to NK-mediated killing. Our 3D model highlighted molecular features that more closely resemble the immunophenotypic variants occurring in vivo and not fully appreciated in classical 2D culture conditions. Thus, based on our results, 3D alginate-based hydrogels might represent a clinical-relevant cell culture platform where to test the efficacy of personalized therapeutic approaches aimed to optimize the current and innovative immune based therapies in a very systematic and reliable way.https://www.frontiersin.org/article/10.3389/fimmu.2019.01876/full3D cancer modelneuroblastomaNK cellsPVRKIRS/HLA-IPD-Ls
spellingShingle Alessandra Marrella
Alessandra Dondero
Maurizio Aiello
Beatrice Casu
Daniel Olive
Stefano Regis
Cristina Bottino
Cristina Bottino
Daniela Pende
Raffaella Meazza
Guido Caluori
Guido Caluori
Roberta Castriconi
Roberta Castriconi
Silvia Scaglione
Silvia Scaglione
Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
Frontiers in Immunology
3D cancer model
neuroblastoma
NK cells
PVR
KIRS/HLA-I
PD-Ls
title Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
title_full Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
title_fullStr Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
title_full_unstemmed Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
title_short Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
title_sort cell laden hydrogel as a clinical relevant 3d model for analyzing neuroblastoma growth immunophenotype and susceptibility to therapies
topic 3D cancer model
neuroblastoma
NK cells
PVR
KIRS/HLA-I
PD-Ls
url https://www.frontiersin.org/article/10.3389/fimmu.2019.01876/full
work_keys_str_mv AT alessandramarrella cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT alessandradondero cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT maurizioaiello cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT beatricecasu cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT danielolive cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT stefanoregis cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT cristinabottino cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT cristinabottino cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT danielapende cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT raffaellameazza cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT guidocaluori cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT guidocaluori cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT robertacastriconi cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT robertacastriconi cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT silviascaglione cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies
AT silviascaglione cellladenhydrogelasaclinicalrelevant3dmodelforanalyzingneuroblastomagrowthimmunophenotypeandsusceptibilitytotherapies